The urokinase receptor associated protein (uPARAP/Endo180): A novel internalization receptor connected to the plasminogen activation system

Trends in Cardiovascular Medicine

Volumn 11, Issue 1, 2001, Pages 7-13

  Engelholm, Lars H ^a   Nielsen, Boye S ^a   Danø, Keld ^a   Behrendt, Niels ^a  

^a FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COLLAGEN TYPE 5; COLLAGENASE 3; GLYCOPROTEIN; MANNOSE RECEPTOR; MEMBRANE PROTEIN; PROTEINASE; RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; UROKINASE RECEPTOR ASSOCIATED PROTEIN;

CANCER INVASION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FETUS CELL; FIBROBLAST; HUMAN; HYPOTHESIS; INTERNALIZATION; LIGAND BINDING; MACROPHAGE; MOLECULAR WEIGHT; NONHUMAN; OSSIFICATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; NEOPLASMS; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATORS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034977870     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00076-7     Document Type: Review

References (61)

1. Basement-membrane stromal relationships; interactions between collagen fibrils and the lamina densa
2. Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2
3. The urokinase-type plasminogen activator system in cancer metastasis; a review
4. The collagen-binding site of type-II units of bovine seminal fluid protein PDC-109 and fibronectin
5. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization
6. A urokinase receptor-associated protein with specific collagen binding properties
7. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator
8. A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking
9. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants
10. The urokinase receptor
11. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
12. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
13. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice
14. Gene targeting and gene transfer studies of the plasminogen/plasmin system; implications in thrombosis, hemostasis, neointima formation, and atherosclerosis
15. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice
16. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice
17. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
18. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction
19. Prevention of metastasis by inhibition of the urokinase receptor
20. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells
21. Plasminogen activators, tissue degradation, and cancer
22. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types
23. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor
24. Plasminogen activation by receptor-bound urokinase
25. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes
26. p180, a novel recycling transmembrane glycoprotein with restricted cell type expression
27. Prediction of the coding sequences of unidentified human genes
28. Molecular cloning of pancreatic group I phospholipase A2 receptor
29. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
30. Cancer invasion and tissue remodeling; common themes in proteolytic matrix degradation
31. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
32. Cloning and expression of a membrane receptor for secretory phospholipases A2
33. Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor
34. The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family
35. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice
36. Metalloproteinases and tissue damage
37. Mechanisms for pro matrix metalloproteinase activation
38. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer
39. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification
40. Bone type V collagen; chain composition and location of a trypsin cleavage site
41. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha-2 macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes
42. An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies
43. Structure-function relationships in the receptor for urokinase-type plasminogen activator
44. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
45. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts
46. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
47. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
48. Mutant mice with scrambled brains; understanding the signaling pathways that control cell positioning in the CNS
49. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis
50. Impaired wound healing in mice with a disrupted plasminogen gene
51. Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor
52. Genes expressed in human tumor endothelium
53. Evolution of a family of receptors containing multiple C-type carbohydrate-recognition domains
54. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor
55. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains
56. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor
57. Urokinase receptor antagonists; discovery and application to in vivo models of tumor growth
58. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase
59. Regulation of integrin function by the urokinase receptor
60. Characterization of a novel member of the macrophage mannose receptor type C lectin family
61. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis